{
  "docId": "019de071-68ef-720e-a74a-8410f5ecfd30",
  "docSlug": "0e46fca7c64e4c4db862b8ec0b9f865c",
  "documentTitle": "GreenLight | SPAC Presentation Deck | 56 slides",
  "authorId": "greenlight",
  "authorName": "GreenLight Biosciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 29,
  "pageCount": 56,
  "prevPage": 28,
  "nextPage": 30,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a biological process diagram to explain the mechanism of action for a gene therapy platform.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-68ef-720e-a74a-8410f5ecfd30/29",
  "deckHref": "/decks/019de071-68ef-720e-a74a-8410f5ecfd30",
  "deckJsonHref": "/decks/019de071-68ef-720e-a74a-8410f5ecfd30.json",
  "deckAnchorHref": "/decks/019de071-68ef-720e-a74a-8410f5ecfd30#slide-29",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.48,
        "x": 0.22,
        "y": 0.77
      },
      "kind": "callout",
      "text": "GreenLight gene therapy architecture targeting potential solutions that: Can edit dividing and nondividing cells; Do not require viral vectors; Achieves long-lasting effect; Are delivered direct to the patient; Can be manufactured at scale",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4b8328c1-977c-4e98-9488-feff4ead3116",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 1,
        "x": 0,
        "y": 0.18
      },
      "kind": "image",
      "text": "Diagram showing RNA-encoded instructions entering a target cell, interacting with ribosomes, and integrating into the nucleus.",
      "attrs": null,
      "subkind": "infographic",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a8b53856-d1de-43d6-90af-2a60741132af",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.9,
        "x": 0.04,
        "y": 0.12
      },
      "kind": "paragraph",
      "text": "Initial research into promising new avenue for Sickle Cell therapy with grant from the Bill & Melinda Gates Foundation",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e3cdd08c-50f9-4670-a82c-813e81a38614",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.92,
        "x": 0.04,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Investor Presentation © 2021 GreenLight Biosciences. All rights reserved. GreenLight confidential. 29",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "34c47487-9102-40e8-b25b-83a01981ed18",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.75,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "Developing proof of concept for novel RNA-based approach to gene therapy",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "862de7e4-4773-4610-9859-82e3bb1fedef",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "92f4a249-b58b-4e01-972c-7dbe96f65530",
      "evidence": "Developing proof of concept for novel RNA-based approach to gene therapy",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 29,
      "from": 28,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "ee14783e-3831-4b9c-b623-3cc690f3db72",
      "evidence": "Slides 28-29 present the vision and solution for a global RNA manufacturing network.",
      "position": 1,
      "objective": "Why now is the right time for GreenLight",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.7,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}